- Home
- MRNA vs DCI Comparison
MRNA vs DCI Comparison
Compare MRNA & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- DCI
- Stock Information
- Founded
- MRNA 2010
- DCI 1915
- Country
- MRNA United States
- DCI United States
- Employees
- MRNA N/A
- DCI N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- DCI Pollution Control Equipment
- Sector
- MRNA Health Care
- DCI Industrials
- Exchange
- MRNA Nasdaq
- DCI Nasdaq
- Market Cap
- MRNA 9.8B
- DCI 9.7B
- IPO Year
- MRNA 2018
- DCI 1987
- Fundamental
- Price
- MRNA $27.16
- DCI $84.25
- Analyst Decision
- MRNA Hold
- DCI Hold
- Analyst Count
- MRNA 15
- DCI 3
- Target Price
- MRNA $37.15
- DCI $80.33
- AVG Volume (30 Days)
- MRNA 10.8M
- DCI 497.5K
- Earning Date
- MRNA 11-06-2025
- DCI 12-02-2025
- Dividend Yield
- MRNA N/A
- DCI 1.42%
- EPS Growth
- MRNA N/A
- DCI N/A
- EPS
- MRNA N/A
- DCI 3.05
- Revenue
- MRNA $3,078,000,000.00
- DCI $3,690,900,000.00
- Revenue This Year
- MRNA N/A
- DCI $4.36
- Revenue Next Year
- MRNA $11.12
- DCI $4.52
- P/E Ratio
- MRNA N/A
- DCI $27.62
- Revenue Growth
- MRNA N/A
- DCI 2.92
- 52 Week Low
- MRNA $23.15
- DCI $57.45
- 52 Week High
- MRNA $56.70
- DCI $84.88
- Technical
- Relative Strength Index (RSI)
- MRNA 52.43
- DCI 61.46
- Support Level
- MRNA $24.25
- DCI $82.59
- Resistance Level
- MRNA $29.20
- DCI $84.88
- Average True Range (ATR)
- MRNA 1.44
- DCI 1.40
- MACD
- MRNA -0.03
- DCI -0.00
- Stochastic Oscillator
- MRNA 58.79
- DCI 87.15
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.